CASOLARI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 6.986
AS - Asia 3.744
EU - Europa 2.467
SA - Sud America 546
AF - Africa 77
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.846
Nazione #
US - Stati Uniti d'America 6.849
SG - Singapore 1.421
CN - Cina 928
IT - Italia 739
DE - Germania 460
VN - Vietnam 436
BR - Brasile 424
UA - Ucraina 345
HK - Hong Kong 283
FI - Finlandia 238
TR - Turchia 216
GB - Regno Unito 201
FR - Francia 129
BD - Bangladesh 121
SE - Svezia 98
RU - Federazione Russa 85
JP - Giappone 83
IN - India 67
MX - Messico 63
CA - Canada 59
ID - Indonesia 44
AR - Argentina 42
NL - Olanda 39
PL - Polonia 36
ZA - Sudafrica 30
IQ - Iraq 23
EC - Ecuador 20
BE - Belgio 17
PK - Pakistan 17
AU - Australia 16
ES - Italia 15
MA - Marocco 14
VE - Venezuela 14
LT - Lituania 13
PH - Filippine 13
CO - Colombia 12
UZ - Uzbekistan 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
MY - Malesia 9
AT - Austria 8
TN - Tunisia 8
TW - Taiwan 8
CL - Cile 7
NP - Nepal 7
UY - Uruguay 7
AL - Albania 6
KE - Kenya 6
PE - Perù 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EG - Egitto 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
HR - Croazia 4
IE - Irlanda 4
JO - Giordania 4
NZ - Nuova Zelanda 4
RO - Romania 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
UG - Uganda 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LI - Liechtenstein 1
Totale 13.834
Città #
Singapore 867
Ashburn 726
Fairfield 641
Woodbridge 556
San Jose 462
Houston 393
Jacksonville 381
Santa Clara 321
Ann Arbor 281
Chandler 279
Hong Kong 279
Beijing 278
Munich 256
Seattle 241
Wilmington 220
Cambridge 205
Washington 199
Ho Chi Minh City 141
Izmir 138
Helsinki 125
Los Angeles 125
Nanjing 123
New York 113
Milan 106
Hanoi 100
Dallas 94
Princeton 86
Tokyo 79
Lauterbourg 73
Ferrara 72
Boardman 56
Rome 52
Chicago 43
San Diego 43
Council Bluffs 41
Mexico City 38
Shanghai 37
Dearborn 35
Warsaw 33
Orem 32
Addison 31
São Paulo 31
Buffalo 30
Jakarta 30
Nanchang 29
Turku 28
Shenyang 27
Hebei 26
Tianjin 25
Toronto 25
Brooklyn 21
Da Nang 21
Hefei 20
Jiaxing 20
Frankfurt am Main 19
London 19
Cardiff 18
Changsha 18
Haiphong 18
Chennai 17
Montreal 17
Atlanta 16
Bologna 16
Denver 16
Guangzhou 16
Moscow 16
Mountain View 16
Hải Dương 15
Kunming 15
Naples 15
San Francisco 15
Brussels 14
Johannesburg 14
Turin 14
Bremen 13
Florence 13
Parma 13
Boston 12
Manchester 12
Redwood City 12
Auburn Hills 11
Jinan 11
Rio de Janeiro 11
Belo Horizonte 10
Blackpool 10
Campinas 10
Jyväskylä 10
Taizhou 10
The Dalles 10
Verona 10
Amsterdam 9
Baghdad 9
Curitiba 9
Dong Ket 9
Falls Church 9
Norwalk 9
Philadelphia 9
Salt Lake City 9
Ningbo 8
Nuremberg 8
Totale 9.324
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 497
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 342
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 338
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 318
Targeting Th2 cells in asthmatic airways 299
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 282
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 257
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 215
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 215
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 213
Activation of NF-kappaB transcription factor in asthma death 211
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 210
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 209
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 205
Cellule staminali e patologia polmonare dell’adulto 204
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 204
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 201
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 196
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 191
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 182
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 179
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 179
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 174
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 171
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 167
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 166
Mechanisms involved in lung cancer development in COPD 165
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 165
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 164
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 164
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 163
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 162
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 160
Pathophysiology of viral-induced exacerbations of COPD 160
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 159
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 159
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 150
COPD immunopathology 150
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 147
New drugs targeting Th2 lymphocytes in asthma 147
COPD pathology in the small airways 145
Increased deposition of activated complement in peripheral lung vessels of smokers 144
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 143
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 143
SAA and lipid metabolism in IPF 134
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 128
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 125
null 121
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 121
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication 120
null 118
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 118
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 117
Trattamento personalizzato dei pazienti con BPCO in fase stabile 117
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 116
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 116
null 114
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease 114
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 108
Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and gro- production in bronchial epithelial cells. 104
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 104
Inhibition of PI-3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice 103
null 102
Expression of adenosine receptors in the peripheral lung from COPD patients. 102
Xanthine-Oxidase System Activation Is Required in Rhinovirus Induced Oxidant Production in Respiratory Epithelial Cells 102
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 101
Scavenger Receptor B1 involvement in COPD pathogenesis 99
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κb and c-Jun N-terminal kinase activation 98
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1 97
Definition and aetiology of infective exacerbations of COPD 96
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia. 96
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease 95
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 94
null 92
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 92
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 91
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 91
null 91
null 91
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 90
null 90
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 89
null 88
null 88
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations 87
null 81
null 81
Ruolo delle infezioni virali nelle riacutizzazioni asmatiche. 77
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 67
null 66
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study 60
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 55
null 51
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 50
Role of transcription factors in the pathogenesis of asthma and COPD 49
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 42
STAT3 and STAT6 activation in lung tissues correlates with inflammatory and clinical traits in COPD 32
Totale 14.006
Categoria #
all - tutte 60.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.651
Totale 63.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 0 111
2021/2022730 26 71 70 54 24 36 26 49 22 58 85 209
2022/2023731 91 21 25 92 120 107 32 61 95 3 54 30
2023/2024353 39 45 14 6 28 55 10 17 6 10 12 111
2024/20252.025 42 52 141 49 234 223 138 154 368 214 224 186
2025/20265.386 447 238 447 616 835 291 611 370 513 589 257 172
Totale 14.006